The β-(1-3)-glucan, which was derived from Saccharomyces cerevisiae, improved the mice’s immune activity by decreasing the ratio of CD4+/CD8+ T cells and reduced the tumor progression in S180 tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.